Celanese (CE)
(Delayed Data from NYSE)
$155.43 USD
-0.62 (-0.40%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $155.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Celanese (CE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$161.33 | $195.00 | $138.00 | 3.38% |
Price Target
Based on short-term price targets offered by 18 analysts, the average price target for Celanese comes to $161.33. The forecasts range from a low of $138.00 to a high of $195.00. The average price target represents an increase of 3.38% from the last closing price of $156.05.
Analyst Price Targets (18)
Broker Rating
Celanese currently has an average brokerage recommendation (ABR) of 2.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 2.44 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 27.78% and 5.56% of all recommendations. A month ago, Strong Buy made up 33.33%, while Buy represented 5.56%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 6 | 6 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 9 | 9 | 9 | 9 | 10 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 2 | 2 | 1 | 1 | 0 |
ABR | 2.67 | 2.67 | 2.44 | 2.44 | 2.41 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
4/1/2024 | BMO Capital Markets | John P Mcnulty | Hold | Hold |
3/15/2024 | Vertical Research Partners | Kevin W Mccarthy | Hold | Hold |
2/26/2024 | Piper Sandler | Charles N Neivert | Hold | Strong Buy |
2/22/2024 | Robert W. Baird & Co. | Ghansham Panjabi | Strong Buy | Strong Buy |
2/22/2024 | Tudor Pickering Holt & Co. | Matthew Blair | Not Available | Strong Sell |
11/28/2023 | Mizuho SecuritiesUSA | John Roberts | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.67 |
# of Recs in ABR | 18 |
Average Target Price | $161.33 |
LT Growth Rate | 22.00% |
Industry | Chemical - Specialty |
Industry Rank by ABR | 69 of 252 |
Current Quarter EPS Est: | 1.91 |